
Genotropin Therapy Enhances Quality of Life in American Males with MS: A 3-Year Study
Reading Time: 2 minutes Introduction Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, leading to a wide range of symptoms that can significantly impair quality of life. In recent years, the use of Genotropin, a recombinant human growth hormone, has been explored as a potential therapeutic option for managing MS symptoms. This article delves into a three-year neurological study conducted on American males with MS to assess the impact of Genotropin therapy on their quality of life. Study Design and Methodology The study involved a cohort of 100 American males aged between 25 and 55 years, all diagnosed...